Announced a growth investment in Epicutis (Signum Dermalogix, Inc.), a science-backed, patent-protected skincare brand.
Epicutis focuses on restoring optimal skin function through biotechnology, offering products designed to reduce inflammation, balance the microbiome, and support long-term skin resilience with minimal formulations
Epicutis focuses on restoring optimal skin function through biotechnology, offering products designed to reduce inflammation, balance the microbiome, and support long-term skin resilience with minimal formulations.